主席李其玲增持东瑞制药5.2万股 每股作价1.22港元

Core Viewpoint - The chairman of the Hong Kong Stock Exchange, Li Qiling, has increased his stake in Dongrui Pharmaceutical (02348) by purchasing 52,000 shares at a price of HKD 1.22 per share, totaling approximately HKD 63,400 [1] Summary by Category Shareholding Activity - After the purchase, the total number of shares held by Li Qiling is approximately 711 million, representing a holding percentage of 47.26% [1] Related Parties - The transaction involves other related parties, specifically Xiong Rongli [1]